PEPTIDE
European patent · EP3380502 · In force
Register entry
- Publication number
- EP3380502
- Application number
- EP16805193
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 23, 2016
- Published
- Oct 3, 2018
- Granted
- Jul 7, 2021
- Protection ends at the latest
- Nov 22, 2036
- Next annual fee due
- Nov 30, 2026
- IPC classes
- C07K 14/47 (2006.01)C07K 4/12 (2006.01)C07K 7/06 (2006.01)
- Priority
- GB 201520544 23.11.2015
- PCT application
- PCT/GB2016/053658 23.11.2016
- PCT publication
- WO2017/089776 01.06.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 1, 2025
Change
Published in Swissreg on 01.12.2025
- Dec 1, 2024
Change
Published in Swissreg on 01.12.2024
- Dec 1, 2023
Change
Published in Swissreg on 01.12.2023
- Dec 1, 2022
Change
Published in Swissreg on 01.12.2022
- May 18, 2022
Change
Published in Swissreg on 18.05.2022
- Nov 3, 2021
Owner
- Owner
- Immunocore Limited, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom, Adaptimmune Limited, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom → Adaptimmune Limited, 101 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom, Immunocore Limited, 92 Park Drive, Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom
Published in Swissreg on 03.11.2021
- Jul 7, 2021
Granted
Published in Swissreg on 07.07.2021
Parties
Holder
Inventor
CHESTER, Fiona
Abingdon Oxfordshire OX14 4RY, GB
POWLESLAND, Alex
Abingdon Oxfordshire OX14 4RY, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.